BARCLAYS PLC - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 66 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q2 2024$0380.0%0.00%
Q1 2024$0380.0%0.00%
Q4 2023$038
-50.0%
0.00%
Q3 2023$076
+100.0%
0.00%
Q2 2023$0
-100.0%
38
-100.0%
0.00%
Q1 2023$134
+7.2%
190,007
+14.0%
0.00%
Q4 2022$125
-99.6%
166,641
+322.2%
0.00%
Q3 2022$34,000
+54.5%
39,470
+97.4%
0.00%
Q2 2022$22,000
-95.4%
20,000
-95.3%
0.00%
Q1 2022$477,000
-60.0%
426,085
-42.9%
0.00%
Q4 2021$1,192,000
+2383.3%
745,588
+3627.9%
0.00%
Q3 2021$48,000
-23.8%
20,0000.0%0.00%
Q2 2021$63,000
-76.3%
20,000
-74.7%
0.00%
Q1 2021$266,00078,988
+987250.0%
0.00%
Q2 2019$080.00%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q4 2023
NameSharesValueWeighting ↓
Tejara Capital Ltd 2,435,806$1,721,8710.88%
Monaco Asset Management SAM 1,316,245$930,4540.28%
DAFNA Capital Management LLC 1,096,513$775,1250.23%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,364,438$5,205,9210.22%
Clearline Capital LP 2,052,709$1,451,0600.22%
Rubric Capital Management LP 10,366,120$7,327,8100.19%
Orbimed Advisors 7,747,891$5,476,9840.11%
Rock Springs Capital Management LP 6,244,897$4,414,5180.10%
683 Capital Management, LLC 2,000,000$1,413,8010.10%
Privium Fund Management (UK) Ltd 177,200$131,1280.10%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders